On this page you can find relevant researchs on drug-related health topics, including HIV, hepatitis C, drug and overdose prevention, harm reduction and drug treatment. You can also find our Clinical Guidelines.

A guide to developing and implementing overdose prevention programs
This guide was developed in response to the growing need among service providers working with drug users in Central and Eastern Europe and Central Asia to introduce overdose prevention work into their services.
SMMGP Clinical Update Dec ‘11/Jan ‘12
This document is very UK focused but has very interesting papers including “Quantitative assessment of time dependent drug-use trends by the analysis of drugs and related metabolites in raw sewage (Norway)”
The Inadequate Treatment of Pain: Collateral Damage from the War on Drugs
This document provides a critical look at the current realities of access to morphine in low-, middle-, and high-income countries.
IDHDP Global Addiction Presentation (audio)
Chris Ford's presentation "The need to challenge unhealthy drug policies to improve drug treatment" at the Global Addiction Conference in Lisbon, Portugal
IDHDP Global Addiction Presentation (slides)
Chris Ford's slide presentation of "The need to challenge unhealthy drug policies to improve drug treatment" presented at the Global Addiction Conference in Lisbon, Portugal.
Addressing Viral Hepatitis in People With Substance Use Disorders
This manual has been developed to provide behavioral health care programs offering substance abuse treatment services information to better address the needs of clients who have viral hepatitis. The manual was developed by the Substance Abuse and Mental Health Services Administration
IDHDP support letter for Norway child protection case
IDHDP sent a letter in support of a young pregnant woman who was being held against her will by child welfare authorities in Norway.
Dr Chris Ford speaks to America's Center for Global Health Policy
Chris Ford speaks about IDHDP on the Infectious Disease Society of America's Center for Global Health Policy blog.
The Voice of Harm Reduction User Rights Edition, November 2011
This issue is dedicated to the Rights of People Who Use Drugs. In the content you will find: Message from an Expert: Mat Southwell, INPUD and Olga Belyaeva, EHRN Steering Committee member; Completing Laws with Rights, review by Mikhail Golichenko, Canadian HIV/AIDS Legal Network and more
Amphetamine Type Stimulants and Harm Reduction
Problematic use of amphetamine-type stimulants (ATS)2 has become a significant health and social problem in East and Southeast Asia, in particular the use of methamphetamine, the most potent amphetamine derivative and most widely used substance in the region.
Share this on: